2022 Revenues ($USD) : $237,146,000
2022 R&D spend : $50,544,000
2022 Number of Employees : 657
Fiscal Year End : 12/31/2021
Company CEO : Doug Godshall, president and CEO

Shockwave Medical has proprietary cardiovascular disease treatment tech involving local delivery of sonic pressure. Sales more than tripled to $237 million last year amid the U.S. launch of the company's Shockwave C². The company expects revenue to roughly double again this year to a range of $465 million to $475 million. –CN